Search

Search Results
Results 21 - 30 of 173 for parkinson
  • Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dothep intended for persons living in Australia.
  • Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dosulepin Viatris (formerly Dosulepin Mylan) intended for persons living in Australia.
  • Drug - 18 Mar 2024
    Consumer Medicine Information (CMI) about Resprim (trimethoprim and sulfamethoxazole) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Invega Trinza (Paliperidone palmitate) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Pramin (metoclopramide hydrochloride) intended for persons living in Australia.
  • Drug - 24 Mar 2023
    Consumer Medicine Information (CMI) about Galantyl (galantamine) intended for persons living in Australia.
  • Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Invega Sustenna (Paliperidone palmitate) intended for persons living in Australia.
  • Drug - 5 Aug 2022
    Consumer Medicine Information (CMI) about Ditropan (oxybutynin hydrochloride -CLOR-ride)) intended for persons living in Australia.
  • Drug - 10 Dec 2021
    Consumer Medicine Information (CMI) about Metomax (paracetamol & metoclopramide hydrochloride) intended for persons living in Australia.
  • Drug - 29 Apr 2021
    Consumer Medicine Information (CMI) about Reminyl (Galantamine hydrobromide) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.